Quarterly report · Q3
6095.TEDINET S100OXHE
Period2021-10-01 → 2022-06-30
Filed2022-08-09
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 36
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥6.4bn | 2021-10-01 → 2022-06-30 | Cons. | Net sales |
| Revenue | ¥7.4bn | 2020-10-01 → 2021-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥5.5bn | 2020-10-01 → 2021-06-30 | Cons. | Net sales |
| Operating income | ¥907m | 2021-10-01 → 2022-06-30 | Cons. | Operating income |
| Operating income | ¥1.4bn | 2020-10-01 → 2021-06-30 | Cons. | Operating income |
| Ordinary income | ¥943m | 2021-10-01 → 2022-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥1.8bn | 2020-10-01 → 2021-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.4bn | 2020-10-01 → 2021-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥943m | 2021-10-01 → 2022-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.4bn | 2020-10-01 → 2021-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥655m | 2021-10-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.3bn | 2020-10-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥943m | 2020-10-01 → 2021-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥651m | 2021-10-01 → 2022-06-30 | Cons. | Profit loss |
| Net income | ¥969m | 2020-10-01 → 2021-06-30 | Cons. | Profit loss |
| Total assets | ¥9.2bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥8.5bn | at 2021-09-30 | Cons. | Assets |
| Total assets | ¥8.0bn | at 2021-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.5bn | at 2022-06-30 | Cons. | Liabilities |
| Total liabilities | ¥1.6bn | at 2021-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥7.7bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥7.0bn | at 2021-09-30 | Cons. | Net assets |
| Net assets / equity | ¥6.6bn | at 2021-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥6.5bn | at 2022-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥5.7bn | at 2021-09-30 | Cons. | Cash and deposits |
| EPS (basic) | ¥30.33 | 2021-10-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥2.59 | 2022-04-01 → 2022-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥60.07 | 2020-10-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥43.82 | 2020-10-01 → 2021-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥8.02 | 2021-04-01 → 2021-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥28.76 | 2021-10-01 → 2022-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥56.25 | 2020-10-01 → 2021-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥41.12 | 2020-10-01 → 2021-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 80.6% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.5% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.8% | at 2021-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2021-10-01 → 2022-06-30 | −¥12m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-10-01 → 2022-06-30 | −¥12m |
| Reconciling Itemsreconciling | segment profit | 2021-10-01 → 2022-06-30 | −¥518m |
| jpcrp040300-q3r_E30650-000Doctor Plat Formreportable segment | revenue | 2021-10-01 → 2022-06-30 | ¥4.9bn |
| jpcrp040300-q3r_E30650-000Doctor Plat Formreportable segment | revenue external | 2021-10-01 → 2022-06-30 | ¥4.9bn |
| jpcrp040300-q3r_E30650-000Doctor Plat Formreportable segment | revenue intersegment | 2021-10-01 → 2022-06-30 | ¥8m |
| jpcrp040300-q3r_E30650-000Doctor Plat Formreportable segment | segment profit | 2021-10-01 → 2022-06-30 | ¥1.3bn |
| jpcrp040300-q3r_E30650-000Healthcare Solutionreportable segment | revenue | 2021-10-01 → 2022-06-30 | ¥1.5bn |
| jpcrp040300-q3r_E30650-000Healthcare Solutionreportable segment | revenue external | 2021-10-01 → 2022-06-30 | ¥1.5bn |
| jpcrp040300-q3r_E30650-000Healthcare Solutionreportable segment | revenue intersegment | 2021-10-01 → 2022-06-30 | ¥4m |
| jpcrp040300-q3r_E30650-000Healthcare Solutionreportable segment | segment profit | 2021-10-01 → 2022-06-30 | ¥100m |
| —segment total | revenue | 2021-10-01 → 2022-06-30 | ¥6.5bn |
| —segment total | revenue external | 2021-10-01 → 2022-06-30 | ¥6.4bn |
| —segment total | revenue intersegment | 2021-10-01 → 2022-06-30 | ¥12m |
| —segment total | segment profit | 2021-10-01 → 2022-06-30 | ¥1.4bn |
| Reconciling Itemsreconciling | revenue | 2020-10-01 → 2021-06-30 | −¥6m |
| Reconciling Itemsreconciling | revenue intersegment | 2020-10-01 → 2021-06-30 | −¥6m |
| Reconciling Itemsreconciling | segment profit | 2020-10-01 → 2021-06-30 | −¥357m |
| jpcrp040300-q3r_E30650-000Doctor Plat Formreportable segment | revenue | 2020-10-01 → 2021-06-30 | ¥4.3bn |
| jpcrp040300-q3r_E30650-000Doctor Plat Formreportable segment | revenue external | 2020-10-01 → 2021-06-30 | ¥4.3bn |
| jpcrp040300-q3r_E30650-000Doctor Plat Formreportable segment | revenue intersegment | 2020-10-01 → 2021-06-30 | ¥5m |
| jpcrp040300-q3r_E30650-000Doctor Plat Formreportable segment | segment profit | 2020-10-01 → 2021-06-30 | ¥1.5bn |
| jpcrp040300-q3r_E30650-000Healthcare Solutionreportable segment | revenue | 2020-10-01 → 2021-06-30 | ¥1.2bn |
| jpcrp040300-q3r_E30650-000Healthcare Solutionreportable segment | revenue external | 2020-10-01 → 2021-06-30 | ¥1.2bn |
| jpcrp040300-q3r_E30650-000Healthcare Solutionreportable segment | revenue intersegment | 2020-10-01 → 2021-06-30 | ¥396,000 |
| jpcrp040300-q3r_E30650-000Healthcare Solutionreportable segment | segment profit | 2020-10-01 → 2021-06-30 | ¥196m |
| —segment total | revenue | 2020-10-01 → 2021-06-30 | ¥5.5bn |
| —segment total | revenue external | 2020-10-01 → 2021-06-30 | ¥5.5bn |
| —segment total | revenue intersegment | 2020-10-01 → 2021-06-30 | ¥6m |
| —segment total | segment profit | 2020-10-01 → 2021-06-30 | ¥1.7bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 329
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)有限責任監査法人 トーマツ | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)伊藤 裕之 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)萬 政広 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 5503206000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 6443320000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 7435418000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 1395926000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 943436000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 1812008000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 943242000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 654585000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 1293475000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 968688000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 647386000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 1331159000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 6606025000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 7654738000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 6980777000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 8037922000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 9158103000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 8538329000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 43.82 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 30.33 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 60.07 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | 41.12 | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | 28.76 | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | 56.25 | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.788 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.806 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.785 | |
| Basic earnings loss per share (5-year summary) | Prior1QuarterDuration | 8.02 | |
| Basic earnings loss per share (5-year summary) | CurrentQuarterDuration | 2.59 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 21599230 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 21620580 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 21599230 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 21620580 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 1100 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 21566400 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 215664 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 24530 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 21592030 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 215664 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 1100 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |